EXPECTED: new Excalibur arrays Illumina
Illumina is introducing a new generation of arrays which will run on the Excalibur platform. End of 2022 two new genotyping arrays with optional enhanced pharmacogenetics will be available, the GSA version 4 and the Global Clinical Research Array (GCRA). Also a new methylation array, the Methylation Screening Array (MSA), will be launched that will fit 48 samples and will be run on the same platform, as well as the MethylEPIC version 2. More information of these new arrays can be found in documentation.
NEW: protein biomarker analysis using Olink platform
From November 2021, Olink proteomics services with 384, 1536 and 3072 explore panels are available at HuGeF.
COVID 19 host genetic initiative
Worldwide there are ongoing efforts by the genetics community to help understand host genetics in relation to the
SARS CoV2 virus, and COVID 19. To facilitate this, HuGe has previously offered free of charge genotyping of proven
COVID 19 cases and discounted genotyping of COVID 19 related cases. Although this offer is no longer valid, as one of
our customers you can still play an important role in this effort by contributing data to a large analysis. The COVID 19
host genetics initiative aims to bring together the human genetics community to generate, share and analyze data to
learn the genetic determinants of COVID 19 susceptibility, severity and outcomes. We very much support this effort
and hope that your genotype data can help this effort to produce useful results. Please join the COVID 19 host genetics
initiative with your data on COVID 19 cases.
For more information, please contact dr. Gaby van Dijk.